Description
Vapreotideisasyntheticpeptideanalogofsomatostatinthatactivatessomatostatin2receptorsandinhibitsneurokinin1receptors.Vapreotideexhibitsanti-inflammatory,antiviral,orexigenic,antihypertensive,andanticancerchemotherapeuticactivities.Inmacrophages,vapreotideinhibitssubstanceP-inducedproductionofIL-8andMCP-1,preventingHIV-1infection.Intheclinicaltreatmentofprostatecancer,vapreotidedecreasesPSAandPAPlevelsandbonepainscores.Additionally,thiscompounddecreasesportalpressureandbloodflow,improvingbleedingcontrolandmortalityratesinclinicalsubjectswithvaricealbleeding.Vapreotidealsoincreasesfoodintakeinvivo.
References
SpitsinS,TulucF,MeshkiJ,etal.AnalogofsomatostatinvapreotideexhibitsBIOLOGicaleffectsinvitroviainteractionwithneurokinin-1receptor.Neuroimmunomodulation.2013;20(5):247-55.PMID:23921645.
TachibanaT,ClineMA,KhanMS,etal.FeedingresponsestocentraladmiNISTrationofseveralsomatostatinanalogsinchicks.CompBiochemPhysiolAMolIntegrPhysiol.2011Jan;158(1):47-51.PMID:20826222.
CalèsP.Vapreotideacetateforthetreatmentofesophagealvaricealbleeding.ExpertRevGastroenterolHepatol.2008Apr;2(2):185-92.PMID:19072353.
González-BarcenaD,SchallyAV,VADIllo-BuenfilM,etal.ResponseofpatientswithadvancedprostaticcancertoadministrationofsomatostatinanalogRC-160(vapreotide)atthetimeofrelapse.Prostate.2003Aug1;56(3):183-91.PMID:12772187.